Cardiorenal Risk Management in Patients with Chronic Kidney Disease: Considering Novel Mechanisms, Treatment Combinations, and Best Practices in Optimizing Care
Tuesday, April 16, 2024
12:15 PM – 1:15 PM ET simulcast
11:15 AM – 12:15 PM CT
10:15 AM – 11:15 AM MT
9:15 AM – 10:15 AM PT
Features:
- Interactive, case-based learning environment
- Downloadable whiteboard animations
- Customize your own personalized poster
This event is not part of the official Internal Medicine Meeting 2024 Education Program. CME credit is provided by organizations other than ACP.
Program Description
This innovative hybrid (live and online) symposium is designed to meet the educational needs of primary care clinicians working with a multidisciplinary team of cardiologists, nephrologists, nurses, pharmacists, and other healthcare providers who care for patients with diabetes to ensure recognition of chronic kidney disease (CKD) risk and institute novel strategies for modifying the risk of CKD and other chronic complications of T2D.
Learning Objectives
After completing the CME activity, learners should be better able to:
- Assess the mechanistic features of agents indicated to reduce the risk of CKD progression, such as SGLT2 inhibitors and MRAs
- Recognize current clinical data and guidelines informing the management of CKD risk across patient groups
- Evaluate updates concerning management of adverse events associated with therapy to reduce the risk of CKD progression, including review of best practices in adverse event monitoring and management
Target Audience
This activity is designed to meet the educational needs of primary care clinicians working with a multidisciplinary team of cardiologists, nephrologists, nurses, pharmacists, and other HCPs to ensure recognition of CKD risk in patients with T2D and novel strategies for modifying CKD risk and the risk of other chronic complications of T2D.
Joint Accreditation Statement
Physician Credit Designation Statement
Med Learning Group designates this virtually live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
Nurses (ANCC) Credit Designation
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.
Pharmacists and Pharmacy Technicians (ACPE) Credit Designation
Med Learning Group designates this activity for a maximum of 1.0 knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits are generally reported during the first week of each month for those who claimed during the month prior.
Disclaimer
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at info@medlearninggroup.com.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at https://www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to participating at info@medlearninggroup.com
Release date: April 16, 2024
Expiration date: April 16, 2024
Estimated time to completion: 1.0 hour
